Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance
暂无分享,去创建一个
I. Wistuba | C. Behrens | J. García-Foncillas | M. Pajares | M. Ponz-Sarvisé | M. Redrado | A. Calvo | P. Nguewa | I. Gil-Bazo | L. Montuenga | R. Pio | J. Agorreta | M. Lozano | C. Garcia-Franco